Stephen C. Glover
2023
In 2023, Stephen C. Glover earned a total compensation of $993.2K as Co-Founder, Chief Executive Officer President and Chairman at ZyVersa Therapeutics, a 33% decrease compared to previous year.
Compensation breakdown
| Bonus | $225,000 |
|---|---|
| Option Awards | $218,217 |
| Salary | $550,000 |
| Total | $993,217 |
Glover received $550K in salary, accounting for 55% of the total pay in 2023.
Glover also received $225K in bonus and $218.2K in option awards.
Rankings
In 2023, Stephen C. Glover's compensation ranked 1,158th out of 2,615 executives tracked by ExecPay. In other words, Glover earned more than 55.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,158 out of 2,615 | 56th |
Division Manufacturing | 689 out of 1,425 | 52nd |
Major group Chemicals And Allied Products | 459 out of 801 | 43rd |
Industry group Drugs | 447 out of 767 | 42nd |
Industry Pharmaceutical Preparations | 302 out of 542 | 44th |
Source: SEC filing on September 9, 2024.
Glover's colleagues
We found two more compensation records of executives who worked with Stephen C. Glover at ZyVersa Therapeutics in 2023.